PROF vs SLGL

The deterministic health profile is critical, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. While the company exhibits strong top-line momentum with 43.10% YoY revenue growth and a healthy gross margin of 70.77%, this is completely offset by a catastrophic profit margin of -264.44%. The company is essentially a high-burn growth play with a very expensive valuation (P/S of 14.99) and a long history of negative earnings. Only the exceptionally high current ratio (12.53) and low debt provide a temporary safety net against insolvency.

SLGL exhibits a critical disconnect between its explosive 1-year price appreciation (+1243%) and its deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 150%, the company suffers from negative gross margins (-17.62%) and a catastrophic operating margin (-497.84%), indicating that the cost of producing its goods exceeds its sales revenue. Despite a strong liquidity position (Current Ratio 4.37) and low debt, the valuation is speculative with a Price/Book of 9.02 and a Price/Sales of 12.36. The stock is currently trading on growth momentum rather than financial viability.